Mountainside Treatment Center

This article examines the challenges of navigating postpartum depression alongside substance use disorder, stressing that specialized, integrated dual-diagnosis care is vital for long-term wellness. It clarifies the critical differences between postpartum depression and the more severe, rare postpartum psychosis, while offering actionable strategies for mothers to maintain...

Federal and state laws, including the Family and Medical Leave Act (FMAL) and the Americans with Disabilities Act (ADA), generally protect employees from termination when seeking addiction treatment, provided they follow the correct legal and procedural steps. These protections allow eligible workers to take necessary medical leave while ensuring their job status and healt...

The article explains that navigating out-of-network rehab nad insurance for addiction treatment can offer access to specialized, flexible, and high-quality care, despite the higher costs often associated with these plans. It also clarifies key insurance mechanisms like deductibles, out-of-pocket maximums, and balance billing, which are essential for families to manage expe...

Living with both schizophrenia and a substance use disorder, known as dual diagnosis, creates complex challenges that impact roughly 40-50% of individuals with schizophrenia. Effective treatment requires an integrated care model that simultaneously addresses both the mental health condition and substance use through comprehensive assessment and evidence-based therapies. Wi...

N-propionitrile brorphine is a highly potent novel synthetic opioid that is appearing as a dangerous, hidden adulterant in illicit drug supplies, often mistaken for fentanyl. Because of its extreme potency and potential for prolonged, deep sedation, it presents a significant overdose risk that frequently requires multiple doses of naloxone to reverse. Essential harm reduct...